Mon, Aug 10, 2026
[Archive]
Volume 11, Issue 3 (Aug 2026)
JNFS 2026, 11(3): 416-424 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shokrani S, Nazarpour V, Sangouni A A, Mohammad Hosseini Azar M R, Alizadeh M. The Effect of Garlic Powder Supplementation on Appetite Control and Cardiometabolic Indices in Patients with Non-Alcoholic Fatty Liver Disease: A Double-Blind Randomized Controlled Clinical Trial. JNFS 2026; 11 (3) :416-424
URL: http://jnfs.ssu.ac.ir/article-1-1523-en.html
URL: http://jnfs.ssu.ac.ir/article-1-1523-en.html
Sina Shokrani 
, Vahid Nazarpour 
, Abbas Ali Sangouni , Mohammad Reza Mohammad Hosseini Azar , Mohammad Alizadeh *
, Vahid Nazarpour , Abbas Ali Sangouni , Mohammad Reza Mohammad Hosseini Azar , Mohammad Alizadeh *
Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (598 Views)
Background: Non-alcoholic fatty liver disease (NAFLD) has become a serious health care challenge. The authors evaluated the effect of garlic powder supplementation on appetite control and cardiometabolic indices in patients with NAFLD. Methods: This double-blind randomized controlled clinical trial was conducted for 12 weeks in ninety patients with NAFLD. The participants were randomly assigned to receive 1600 mg/d garlic powder (treatment group) or 1600 mg/d starch (placebo group). Appetite and cardiometabolic indices such as atherogenic index of plasma (AIP), castelli risk index II (CRI-II), atherogenic coefficient (AC), and cardiometabolic index (CMI) were assessed at baseline, middle and after intervention. Results: A total of 88 participants completed the trial. No difference was found between groups in baseline values of appetite parameters, AIP, AC and CMI. Only CRI-II was significantly higher in the treatment group (P=0.01). After intervention, the treatment group compared to the placebo group showed significant improvements in hunger (P<0.001), fullness (P=0.001), desire to eat (P=0.002), ability to eat (P<0.001), AIP (P<0.001), CRI-II (P<0.001), AC (P<0.001), and CMI (P<0.001). Conclusions: Garlic improves appetite and cardiometabolic indices.
Type of article: orginal article |
Subject:
public specific
Received: 2025/11/20 | Published: 2026/08/19 | ePublished: 2026/08/19
Received: 2025/11/20 | Published: 2026/08/19 | ePublished: 2026/08/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
